Cue Biopharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Cue Biopharma generated cash of -$39,961,000, which is more than the previous year. Cash used in financing activities reached the amount of $11,860,000 last year. Net change in cash is therefore -$3,099,000.
Cash Flow
| 2015 | -1.65M | -804.28K | 8.86M |
|---|---|---|---|
| 2016 | -5.96M | -516.01K | 15.00M |
| 2017 | -12.19M | -1.20M | 62.00M |
| 2018 | -26.41M | -20.35M | 4.18M |
| 2019 | -30.79M | 3.44M | 50.78M |
| 2020 | -32.49M | 4.45M | 58.61M |
| 2021 | -38.83M | 9.10M | 19.23M |
| 2022 | -41.80M | -24.60M | 53.65M |
| 2023 | -39.96M | 25.00M | 11.86M |
CUE Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 51.76M | 64.52M | 75.01M | 44.44M | 21.00M | 63.58M | 14.92M | 6.40M | 0 |
Operating activities | |||||||||
Net income | -50.73M | -53.01M | -44.16M | -44.78M | -36.69M | -38.98M | -23.23M | -7.65M | -1.92M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 3.43M | 1.80M | -1.77M | 1.05M | 5.16M | 760.01K | 419.56K | 202.08K | 44.81K |
Stock-based compensation expense | 8.18M | 9.49M | 11.51M | 10.48M | 6.52M | 0 | 2.77M | 889.55K | 0 |
| Deferred income tax benefit | 8.18M | 9.49M | 11.51M | 10.48M | 6.52M | 0 | 2.77M | 889.55K | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -1.64M | 3.08M | -1.72M | -662.58K | -754.89K | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 4.79M | 4.85M | -509.79K | 0 | 0 | 0 | 0 |
Accounts payable | 770K | 83.11K | 520.39K | 741.26K | -1.15M | 376.14K | 561.58K | 0 | 177.81K |
Cash generated by operating activities | -39.96M | -41.80M | -38.83M | -32.49M | -30.79M | -26.41M | -12.19M | -5.96M | -1.65M |
Investing activities | |||||||||
Purchases Of Investments | 0 | -29.44M | -4.58K | -9.94M | -15.13M | -39.5M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -170.74K | -913.03K | -595.25K | -46.35K | -1.85M | -1.20M | -515.97K | -754.28K |
Acquisitions Net | 0 | 6.20K | 4.58K | 83.69K | 127.5K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 25.00M | -24.60M | 9.10M | 4.45M | 3.44M | -20.35M | -1.20M | -516.01K | -804.28K |
Financing activities | |||||||||
Common Stock Issued | 13.38M | 39.3M | 17.38M | 56.68M | 48.99M | 4.16M | 66.15M | 16.41M | 10.00M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -750.18K | -271.05K | -91.02K | 0 | -4.15M | -1.40M | -1.13M |
Repayments of term debt | -2M | 10M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 11.86M | 53.65M | 19.23M | 58.61M | 50.78M | 4.18M | 62.00M | 15.00M | 8.86M |
Net Change In Cash | -3.09M | -12.75M | -10.49M | 30.57M | 23.43M | -42.58M | 48.60M | 8.52M | 6.40M |
Cash at end of period | 48.66M | 51.76M | 64.52M | 75.01M | 44.44M | 21.00M | 63.53M | 14.92M | 6.40M |
| Data source | Data source | Data source | Data source | Data source | Data source |